Prior authorization — document ALL clinical criteria and concordant imaging

Prior authorization must document that ALL listed clinical criteria and concordant MRI/CT imaging are met before elective primary lumbar decompression for neurogenic claudication (i.e., significant daily pain with functional impairment; pain provoked by walking/positions and improved with sitting/forward flexion; failure of required conservative therapies; and MRI/CT showing neural structure compression concordant with symptoms and exam).

• Subjective symptoms and symptom pattern documented
• Evidence of failed conservative therapies documented
• MRI/CT report showing neural compression concordant with symptoms and exam

Prior authorization — failed conservative care required (≥2 modalities, ~6 weeks each)

Prior authorization must include documentation of failed conservative care: at least two conservative treatments (e.g., provider-directed exercise program and prescription-strength medications), each typically for six (6) weeks unless contraindicated.

• Provider-directed exercise program prescribed for 6 weeks
• Prescription-strength analgesics/steroids/gabapentinoids/NSAIDs for 6 weeks
• Alternatively, epidural steroid injection(s)/selective nerve root block(s) at the same level(s) may count

Prior authorization required to confirm procedure-specific criteria

Submit prior authorization to confirm that the request meets the specific criteria for lumbar decompression, interlaminar device use (Coflex), or lumbar corpectomy, including indication and all procedure-specific constraints.

• Confirmation that initial decompression criteria are met for Coflex use
• Corpectomy indication and extent documented when applicable
• Verification that all device- and procedure-specific criteria are satisfied

Prior authorization for implant/device procedures (interlaminar/interspinous)

Prior authorization is implied and expected for procedures involving interlaminar or interspinous devices, given explicit device coverage limitations and investigational stance for many stabilization/distraction implants.

• Device implantation requests (e.g., Coflex, interspinous spacers) should be submitted for prior authorization
• Investigational/stabilization devices (interspinous spacers) may be denied if considered investigational

Prior authorization — required CPT/levels/ICD-10 and independent imaging review

Prior authorization submissions must include CPT codes, the involved disc level(s) or motion segments, ICD-10 diagnosis codes, and an independent radiologist's report of the most recent CT, MRI, or myelography; also include detailed nonsurgical treatment history and responses.

• CPT codes and planned surgical levels/motion segments
• ICD-10 diagnosis codes
• Independent radiologist report of most recent CT/MRI/myelography
• Detailed nonsurgical treatment type, duration, frequency, and response

Repeat procedure timeframe — >12 weeks and prior criteria met

For repeat lumbar decompression at the same level, prior authorization or review must document that more than 12 weeks have elapsed since the prior decompression and that initial decompression criteria were previously met.

• Elapsed time since prior decompression: >12 weeks
• Documentation that initial decompression criteria were satisfied previously

Prior authorization expected for interspinous/interlaminar devices

Prior authorization is expected for implantation of interspinous/interlaminar devices and related procedures and must meet FDA labeling and NASS guidance where applicable (e.g., Coflex labeling requirements).

• Device requests must align with FDA indications and device-specific labeling
• Demonstrate required prior non‑operative therapy when specified by device labeling

Applicability to product types — contract/product dependent

Policy criteria apply only to services covered by the member's product; if a product does not cover a service (e.g., certain Medicare HMO‑DSNP cases), medical policy criteria do not apply and product-specific guidance governs.

• Verify member product coverage before applying medical policy criteria
• Refer to Medicaid or product-specific coverage lines when Medicare HMO‑DSNP does not cover a service

Conservative therapy requirement — ≥2 treatments including 6-week trials

Providers must document at least two conservative treatments prior to elective surgery, including a 6‑week provider‑directed exercise program AND 6 weeks of prescription‑strength medications (unless contraindicated).

• 6 weeks of provider-directed exercise program (physical therapy/chiropractic/physician-directed)
• 6 weeks of prescription-strength analgesics/steroids/gabapentinoids/NSAIDs

Conservative care prerequisites — trial of ≥2 treatments (6 weeks each)

Prior authorization requires evidence of a trial of at least two conservative treatments (e.g., 6 weeks of provider-directed exercise and 6 weeks of prescription medications) unless contraindicated.

• Document type and duration of each conservative therapy
• Explain contraindications if a therapy was not attempted

Step requirement for repeat decompression — prior criteria must have been met

Repeat lumbar decompression requests must document that the original conservative and initial decompression criteria were previously met before considering repeat surgery.

• Evidence that initial decompression criteria were satisfied at time of prior procedure
• If prior conservative trials applied, document those treatments and responses

Nonsurgical treatment documentation — detail type, duration, frequency, response

Providers must document trials of provider‑directed nonsurgical treatments (e.g., interventional pain management, physical therapy, chiropractic care, or active exercise program) including duration, frequency, and response; if contraindicated, document why.

• Specify type, duration, frequency, and response for each nonsurgical treatment
• If treatment was contraindicated, provide supporting rationale

Conservative management prerequisite — required except in urgent/emergent cases

Provider‑directed non‑surgical management is a usual prerequisite for elective decompression but may be waived for confirmed urgent/emergent indications.

• Confirm non-surgical management trials for non-urgent cases
• For urgent/emergent cases document the specific exempting diagnosis

Conservative therapy prior to device placement — follow FDA/NASS expectations

FDA labeling and NASS recommendations expect non‑operative treatment before device placement; for example, Coflex labeling requires at least six months of non‑operative treatment prior to implantation.

• Document duration of prior non-operative therapy when device labeling requires it (e.g., Coflex ≥6 months)
• Align device requests with NASS and FDA guidance

Clinical symptom documentation — daily significant pain and positional pattern

Document the individual's subjective symptoms demonstrating daily significant pain with functional impairment and the typical positional symptom pattern (worse with standing/walking or relieved by sitting/forward flexion) concordant with exam and imaging.

• Daily significant pain causing functional impairment (examples listed)
• Symptom provoked by walking/extension and pattern (worse with standing/walking or improved by sitting/flexion)

Conservative therapy documentation — failure or <50% improvement after ≥2 measures

Document failure or less than clinically meaningful improvement (<50% global assessment) after at least two conservative measures (e.g., 6 weeks of provider‑directed exercise and 6 weeks of prescription medications or epidural steroid injections at same level).

• Record global assessment showing <50% improvement for each treatment
• Include dates and durations for each conservative therapy trial

Required clinical documentation — symptoms, exam, and objective tests

Required clinical documentation must include subjective symptoms (daily significant pain and radiating pain to buttock(s)/leg(s)), positive physical exam findings (e.g., positive or crossed straight leg raise, dermatomal sensory deficit, motor weakness, reflex changes), and imaging (MRI/CT) showing neural compression concordant with symptoms.

• Specific positive physical exam findings documented
• MRI/CT demonstrating neural compression concordant with symptoms and exam

Imaging and clinical concordance — MRI/CT evidence required

Include MRI/CT reports that identify neural structure compression at the requested level(s) concordant with the individual's symptoms and physical exam, and specify the cause (e.g., herniated disc, synovial/arachnoid cyst, central/lateral/foraminal stenosis, osteophytes).

• Imaging must show neural compression at requested level(s) concordant with symptoms
• Specify radiographic cause of compression in imaging reports

Interlaminar device documentation — open procedure, levels, and spondylolisthesis

For FDA‑approved interlaminar decompression device use (e.g., Coflex), document that the device is intended for open lumbar decompression (not percutaneous), list the number and levels (1–2 levels between L1–L5), and note presence/absence of Meyerding Grade 1 spondylolisthesis as applicable.

• Statement that device use is for open decompression and not performed with fusion
• Specify one or two lumbar levels (L1–L5)
• Document Meyerding Grade 1 spondylolisthesis if present

Corpectomy documentation — extent, indication, and fusion requirement

For lumbar corpectomy prior authorization and documentation must indicate the extent of vertebral body removal (complete or at least one‑third), the indication (infection, trauma, tumor, or compression at/behind vertebral body), and that corpectomy will be performed with lumbar fusion when required due to iatrogenic instability.

• Extent of resection (≥ one‑third vertebral body)
• Indication for corpectomy (infection, trauma, tumor, compression)
• Statement that corpectomy will be performed with fusion when iatrogenic instability results

Required documentation for repeat decompression — >12 weeks and prior criteria met

For repeat decompression requests, document elapsed time since prior decompression (>12 weeks) and show that criteria for an initial lumbar decompression were met at the time of the prior procedure.

• Elapsed time >12 weeks since prior decompression
• Evidence that initial decompression criteria were met previously

Required clinical documentation for urgent/emergent indications — identify specific diagnoses

For urgent/emergent indications, explicitly identify the diagnosis (e.g., epidural hematoma; discitis, epidural abscess, osteomyelitis; primary or metastatic neoplastic disease causing pathologic fracture/cord compression/instability; cauda equina syndrome; or severe incapacitating pain) in documentation to justify waiver of usual prerequisites.

• Specify the urgent/emergent diagnosis being treated
• State that usual prerequisites (e.g., conservative trials) are waived due to urgency

Required clinical and radiographic documentation — mechanical pain, prior surgery, instability

Documentation should indicate presence of significant mechanical back pain when applicable, prior decompression at the intended segment if required by device guidance, and radiographic assessment for spondylolisthesis grade, flexion‑extension instability, prior fusion, and other FDA contraindications.

• Document mechanical back pain characteristics if present
• Provide flexion‑extension views for instability assessment (≥3 mm translation)
• Document prior fusion or decompression at index level when relevant

Product and contract dependency — verify product coverage

Services are contract dependent; verify the member's product covers the requested service — if not covered by the product, medical policy criteria do not apply.

• Confirm product coverage before applying policy criteria
• Follow product-specific coverage lines (Medicaid/Medicare exceptions)

Denial risk — radiologic concordance missing

Lack of MRI/CT evidence showing neural structure compression concordant with symptoms at the requested level(s) is a common denial trigger.

• Ensure imaging demonstrates neural compression concordant with symptoms and exam
• Absence of concordant imaging may lead to denial

Denial risk — inadequate conservative therapy documentation

Requests may be denied if documentation does not show at least two conservative therapies (e.g., 6‑week PT and 6‑week pharmacologic trial) unless clearly contraindicated.

• Document two distinct conservative therapies with dates/durations
• Provide rationale if therapies were contraindicated

Denial risk — imaging lacks listed pathologic cause of compression

Procedures may be denied if imaging does not show neural structure compression caused by a listed pathology (herniated disc, synovial/arachnoid cyst, central/lateral/foraminal stenosis, osteophytes).

• Imaging must specify the cause of compression at requested level(s)
• Lack of listed pathologic cause on imaging may trigger denial

Denial risk — behavioral health exclusion if unmanaged

Coverage may be precluded when unmanaged significant mental or behavioral health disorders are present (e.g., major depressive disorder, chronic pain syndrome, opioid or alcohol use disorders) until those conditions are managed.

• Document absence of unmanaged significant behavioral health disorders
• If present, include treatment/management plan

Denial risk — not indicated scenarios and investigational devices

Procedures may be denied if performed solely for annular tears, concordant discography, MR spectroscopy results, or degenerative disc disease; stabilization/distraction implants and many interspinous devices are investigational and may be denied.

• Do not base medical necessity solely on annular tears or discography/MR spectroscopy
• Investigational interspinous/spacer devices may be denied

Denial risk — incomplete prior authorization documentation

Incomplete prior authorization requests lacking required CPT codes, disc levels/motion segments, ICD-10 codes, detailed nonsurgical treatment history and responses, or independent radiologist imaging reports risk denial.

• Include CPT codes, planned operative levels, and ICD-10 codes
• Provide independent radiologist report and reconcile discrepant interpretations
• Detail nonsurgical treatment history with responses

Denial risk — lack of urgent/emergent documentation

Absence of documentation supporting an urgent/emergent indication (when claimed) — such as epidural hematoma, infection, neoplastic compression, or incapacitating pain — may lead to denial if usual criteria are otherwise required.

• Provide clear documentation of the urgent/emergent diagnosis and exams
• State which usual prerequisites are being waived and why

Denial risk — contraindications and not‑indicated scenarios for interspinous devices

Interspinous/interlaminar devices are not indicated and would be denied when NASS/FDA criteria are not met, including Grade 2+ spondylolisthesis, degenerative scoliosis, dynamic instability (≥3 mm translation), prior fusion at index level, or other FDA-listed contraindications.

• Document spondylolisthesis grade and flexion‑extension instability
• Confirm absence of FDA contraindications (osteoporosis, morbid obesity BMI>40, active infection, etc.)

Denial risk — CMS coverage gap may affect Medicare authorizations

No specific National or Regional Medicare coverage decisions address lumbar decompression and interspinous process decompression devices; absence of CMS determinations may affect authorization for Medicare products.

• Verify local Medicare/contract guidance for Medicare products
• Be aware CMS has no specific coverage determination for these services